HURLY STEPHEN A 4
4 · Eleven Biotherapeutics, Inc. · Filed Apr 11, 2018
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-04-09+250,000→ 250,000 totalExercise: $1.50Exp: 2028-04-08→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]On April 9, 2018, the reporting person was awarded options to purchase 250,000 shares of common stock of Eleven Biotherapeutics, Inc. (the "Company"), which options vest 6.25% every three months over four years, provided the reporting person is employed by the Company on each such vesting date.